Hedge Fund and Insider Trading News: John Paulson, Michael Burry, Mike Novogratz, Paul Singer, Bluebell Capital Partners, Tiger Global Management, ExodusPoint Capital, Crowdstrike Holdings Inc (CRWD), aTyr Pharma Inc (LIFE), and More

Page 2 of 2

ExodusPoint has Poached Two Star Portfolio Managers to Supercharge Macro Trading at the $14 Billion Fund (Business Insider)
ExodusPoint Capital is looking to supercharge its macro trading business, and it has poached two top portfolio managers to aid the effort, sources familiar with the matter told Insider. Pablo Duran Steinman, head of macro at the family office of George Soros, is joining Michael Gelband‘s nearly $14 billion multi-strategy fund ExodusPoint, the sources said. Sources said that Mukesh Murarka, a macro portfolio manager at Edward Eisler’s $4.5 billion Eisler Capital, is also joining the firm.

A $200 Million Crypto Quant Offers Funds That Cut Volatility (Bloomberg Quint)
A quant hedge fund is launching active crypto-investing strategies in the U.S. with an ambitious pitch: Get exposure to the virtual-money boom with less of that crazy volatility. Cambrian Asset Management is set to offer two trusts next month tied to Bitcoin and Ethereum respectively, it said in a Wednesday statement. The $200 million firm based in Mill Valley, California, is among a growing slate of institutional money managers offering active trades for the crypto-curious. With executives from Winton Capital and Millennium Management, Cambrian has run a digital-asset fund over the past three years for clients.

These Are The 10 Top Stock Holdings Of Paul Singer (Entrepreneur)
Paul Singer is a hedge fund magnate, who founded Elliott Management in 1977 with $1.3 million. The hedge fund firm now has over $45 billion in assets under management. Though Singer has been diversifying the investments across a variety of assets, he is known for activist positions as well. His firm has pushed for changes at several companies, including Twitter, AT&T and SoftBank. Let’s take a look at the ten top stock holdings of Paul Singer.

Tiger Global’s $6 Billion-Plus Payday (Institutional Investor)
The Tiger Cub hit it big with the Toast and Freshworks IPOs. What a day for the folks at Tiger Global Management. The venture capital and hedge fund giant made more than $6 billion on Wednesday alone from the wildly successful initial public offerings of Toast and Freshworks.

Evergrande Collapse could be ‘Worse’ than Lehman for China, According to Man Who Predicted Enron Collapse (Fox Business)
The collapse of embattled Chinese property developer Evergrande Group could prove to be “far worse” for investors in China than a “Lehman-type situation,” according to Jim Chanos, the veteran short seller who predicted Enron’s collapse two decades ago. BEIJING UNLIKELY TO SAVE EVERGRANDE, REPORT SAYS. The collapse of Evergrande — which has amassed more debt than any other real estate developer in the world — could halt the real estate boom that’s driven economic growth in China for much of the past decade, Chanos told the Financial Times. “There’s lots of Evergrandes out there in China — Evergrande just happens to be one of the biggest,” the founder of New York-based hedge fund Kynikos Associates said “But all the developers look like this. The whole Chinese property market is on stilts.”

Thursday 9/23 Insider Buying Report: LIFE, CRDF (Nasdaq.com)
On Monday, aTyr Pharma (LIFE)’s Director, Paul Schimmel, made a $2M purchase of LIFE, buying 250,000 shares at a cost of $8.00 each. Schimmel was up about 57.4% on the purchase at the high point of today’s trading session, with LIFE trading as high as $12.59 at last check today. aTyr Pharma is trading up about 7.9% on the day Thursday. Before this latest buy, Schimmel made one other buy in the past twelve months, purchasing $199,000 shares at a cost of $3.98 each. And on Tuesday, Director Gary W. Pace bought $202,500 worth of Cardiff Oncology (CRDF), buying 30,000 shares at a cost of $6.75 each. Before this latest buy, Pace bought CRDF on 3 other occasions during the past year, for a total cost of $147,858 at an average of $10.20 per share. Cardiff Oncology is trading up about 4.3% on the day Thursday. Pace was up about 9.6% on the purchase at the high point of today’s trading session, with CRDF trading as high as $7.40 at last check today.

Notable Crowdstrike Holdings Insider Trades $3.57 Million In Company Stock (Benzinga)
Colin Black, Chief Operating Officer at Crowdstrike Holdings (NASDAQ:CRWD), made a large buy and sell of company shares on September 22, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission states that Colin Black exercised options to purchase 3,125 Crowdstrike Holdings shares at a price of ($0.00) per share for a total of ($0.00) on September 22. They then sold their shares on multiple transactions in the open market. They sold at prices ranging from $252.89 to $254.70 to raise a total of $3,572,569 from the stock sale.

The Chief Investment Officer of Magnit PJSC (Other OTC: MGJNF) is Selling Shares (Analyst Ratings)
Yesterday, the Chief Investment Officer of Magnit PJSC (MGJNF), Bodrov Andrey Yurievich, sold shares of MGJNF for $21.93M. In addition to Bodrov Andrey Yurievich, 2 other MGJNF executives reported Sell trades in the last month. MGJNF’s market cap is $9.28 billion and the company has a P/E ratio of 20.50. The insider sentiment on Magnit PJSC has been negative according to 20 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.

Page 2 of 2